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Abstract: Three novel heteroaromatic hydrazone derivatives bearing vic-dioxime groups (L
1H2: 
5-methyl-2-furfural hydrazone glyoxime, L
2H2: 3-acetylpyridine hydrazone glyoxime and L
3H2: 
4-acetylpyridine  hydrazone  glyoxime)  and  their  Ni(II),  Cu(II)  and  Co(II)  complexes  were 
prepared.  They  were  characterised  by  elemental  analysis,  gel  permeation  chromatography 
(GPC), FT-IR, UV, 
1H NMR and 
13C NMR. The antimicrobial activities of compounds L
1H2, 
L
2H2, L
3H2 and their Ni(II), Cu(II) and Co(II) complexes were evaluated using the disc diffusion 
method against 13 bacteria and 5 yeasts. The minimal inhibitory concentrations (MICs) against 3 
bacteria  and  3  yeasts  were  also  determined.  Among  the  test  compounds  attempted,  L
1H2, 
[Co(L
1H)2(H2O)2],  [Ni(L
2H)2],  [Cu(L
2H)2],  L
3H2,  [Ni(L
3H)2  and  [Co(L
3H)2(H2O)2]  showed  some 
activities against certain Gram-positive bacteria and  some of the yeasts tested. 
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INTRODUCTION 
 
Schiff base ligands are well known for their wide range of applications in pharmaceutical 
and  industrial  fields  [1-3].  Moreover,  the  hydrazone  group  plays  an  important  role  of  the 
antimicrobial and possesses interesting antibacterial, antifungal [4-6] and anti-tubercular activities 
[7-12].  In  addition,  their  varied  coordinating  behaviour  makes  them  interesting  candidates  for 
metal-based drugs. Generally, the ligands act synergistically with metals towards their biological 
activity [11, 12]. 
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  Hydrazones possessing an azomethine proton (-NHN=CH-) constitute an important class of 
compounds for new drug development. Many researchers have synthesised these compounds as 
well as their metal complexes as target structures and evaluated their biological activities. These 
observations have guided the development of new hydrazones with varied biological activities [13]. 
The biological activity of complexes derived from hydrazones have been studied and contrasted 
with regard to their antibacterial, antitumoral, antiviral, antimalarial and antitubercular properties 
[14]. It has also been shown that the azomethine N, which has a lone pair of electrons in an sp
2 
hybridised orbital, is biologically important [15].  
  Oximes are becoming increasingly important as analytical, biochemical and antimicrobial 
reagents  and  they  have  received  attention  due  to  their  use  as  liquid  crystals  and  dyes  [16].  
Coordination  compounds  of  oximes  also  receive  considerable  attention  due  to  their  structural 
features. A large amount of work has been accumulated in areas such as structural stability and 
reactivity,  biochemical  modelling and synthesis  of  molecules with unusual electronic properties 
[e.g. 17, 18]. However, detailed literature survey reveals that there is only a little investigation made 
so far on the synthesis of metal hydrazone-oxime chelates. In continuation of our interest in the 
chemistry and biology of transition metal hydrazone-oxime chelates [19], we now carry out another 
systematic study of their synthesis and biological activity.   Herein, the synthesis of the novel 5-
methyl-2-furfural hydrazone glyoxime (L
1H2), 3-acetylpyridine hydrazone glyoxime (L
2H2) and 4-
acetylpyridine hydrazone glyoxime (L
3H2) as well as their complexes with Ni(II), Cu(II) and Co(II) 
ions are described and their antimicrobial properties are evaluated. 
 
EXPERIMENTAL 
 
The 
1H  and 
13C  NMR  spectra  were  recorded  in  DMSO-d
6  on  a  Bruker-400  MHz 
spectrophotometer  using  tetramethylsilane  as  an  internal  reference.  The  apparent  resonance 
multiplicity was described as: s (singlet), br s (broad singlet), d (doublet), dd (doublet of doublets), t 
(triplet), q (quartet) and m (multiplet). Infrared spectra were recorded in the range 400-4000 cm
-1 on 
Spectrum  900  by  Varian.  Electronic  spectra  were  recorded  on  a  Shimadzu  UV1601 
spectrophotometer. Elemental analysis was carried out using PerkinElmer CHNS/O 2400.  Room 
temperature magnetic susceptibility measurements were carried out using a Sherwood-Scientific 
Gouy magnetic balance (Calibrant: Hg[Co(SCN)4]).  
Cobalt(II)  chloride  hexahydrate  (Merck),  nickel(II)  chloride  hexahydrate  (Merck), 
copper(II)  chloride  dihydrate  (Merck),    5-methyl-2-furfuraldehyde  (Merck),  3-acetylpyridine 
(Merck)  and  4-acetylpyridine  (Merck)  were  used  as  received  for  the  sythesis  of  ligands  and 
complexes. Anti-glyoximehydrazine (GH2) was prepared according to a reported procedure [20]. 
Commercially available pure grade solvents, dried and purified by conventional procedure  were 
used. 
 
Synthesis 
  
General procedure for the synthesis of ligands 
 
L
1H2,  L
2H2  and  L
3H2  were  synthesised  from  the  starting  materials,  namely  anti-
glyoximehydrazine (GH2) [20] (Scheme 1), 5-methyl-2-furfuraldehyde (for L
1H2), 3-acetylpyridine 
(for L
2H2) and 4-acetylpyridine  (for L
3H2),  using glacial acetic acid as a catalyst (Schemes 2 and 
3). A cooled (5C) solution of ketone or aldehyde (1 mmol) in ethanol was added dropwise into a 28 
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cooled solution (5C) containing 1 mmol (0.118 g) of anti-glyoximehydrazine (GH2) and 3-5 drops 
of acetic acid with constant stirring. After the addition of aldehyde or ketone was completed, the 
solution was stirred for 2-4 hours at room temperature. The resulting solid compounds were filtered 
off, washed with water and ethanol and dried at room temperature in a vacuum oven. The results of 
the spectroscopic and composition analyses are as follows. 
L
1H2: yield  70 %;  m.p. 118C;  colour yellow; IR (KBr, cm
-1) 3256 (N-H), 3124 (O-H), 
3068 (C-Harom.), 1608  (C=Noxime), 1644 (C=Nhydr.), 953 (N-O); 
1H-NMR (DMSO, ppm) 10.18 s, 1H 
(NH), 11.50–10.65 s, 2H (OH), 6.70 s, 1H (CH=NOH), 6.60 d (J 4.66 Hz), 2H (Ar-H), 7.80 s, 2H (-
CH=N-NH), 2.20 s, 3H (-CH3);  
13C-NMR (DMSO, ppm) 158.80 (-CH=N-NH-), 154.64 (N-NH-
C=N-OH), 150.34 (C-CH=N-OH),  148.48, 147.67, 141.13, 126.33 (Ar-C), 14.14 (-CH3); UV-Vis 
(DMSO, λmax/nm) 262, 394. For C8H10O3N4 (210.190 g.mol
–1), calculated:  45.71 % C, 4.80 % H, 
26.66 % N; found: 45.65 % C, 4.46 % H, 26.24 % N. 
L
2H2: yield  60 %;  m.p. 146.5C;  colour yellow; IR (KBr, cm
-1) 3364 (N-H), 3180 (O-H), 
3066 (C-Harom.), 1605 (C=Noxime), 1656 (C=Nhydr.), 962 (N-O); 
1H-NMR (DMSO, ppm): 8.82 s, 1H 
(NH), 11.50–10.70 s, 2H (OH), 7.82 s, 1H (CH=NOH), 8.70 s, 1H (Ar-H),  8.50 d (J 6.0 Hz), 1H, 
7.94 d (J 7.0 Hz), 1H, 7.53 t (J 7.6 Hz), 1H (Ar-H), 2.13 s, 3H (-CH3);  
13C-NMR (DMSO, ppm) 
154.06  (-CMe=N-NH-),  149.83  (N-NH-C=N-OH),  147.58    (C-CH=N-OH),    146.47,  141.86, 
134.45,  133.60,  124.08  (Ar-C),  12.69  (-CH3);  UV-Vis  (DMSO,  λmax/nm)  260.  For  C9H11O2N5 
(221.216 g.mol
–1), calculated:  48.86 % C, 5.01 % H, 31.66 % N; found: 48.68 % C, 5.52 % H, 
30.98 % N.  
L
3H2: yield  60 %;  m.p. 136
oC;  colour yellow; IR (KBr, cm
-1) 3340 (N-H), 3161 (O-H), 
3073 (C-Harom.), 1605 (C=Noxime), 1640 (C=Nhydr.), 960 (N-O); 
1H-NMR (DMSO, ppm) 8.92 s, 1H 
(NH), 11.60–10.87 s, 2H (OH), 7.61 s, 1H (CH=NOH), 8.27 d (J 6.8 Hz) 4H (Ar-H), 2.19 s, 3H     
(-CH3);  
13C-NMR (DMSO, ppm) 151.45 (-CMe=N-NH-), 150.50 (N-NH-C=N-OH), 146.17 (C-
CH=N-OH), 143.34, 141.68, 121.96 (Ar-C), 12.20  (-CH3); UV-Vis (DMSO, λmax/nm) 262.  For 
C9H11O2N5 (221.216 g.mol
–1), calculated:  48.86 % C, 5.01 % H, 31.66 % N; found: 48.69 % C, 
5.34 % H, 31.37 % N.    
 
 
 
                        Scheme 1. Synthesis of anti-glyoximehydrazine [20] 
 
 
 
 
 
 
 
 
 
             Scheme 2. Synthesis of 5-methyl-2-furfuraldehyde hydrazone glyoxime (L
1H2) 
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Scheme 3. Synthesis of  3-acetylpyridine hydrazone glyoxime (L
2H2) and 4-acetylpyridine 
hydrazone glyoxime (L
3H2) 
 
Synthesis of the Ni(II), Cu(II) and Co(II) complexes of ligands 
 
A solution of a metal salt (1 mmol: 0.237 g of NiCl2.6H2O, 0.170 g of CuCl2.2H2O or  0.237 
g of CoCl2.6H2O in 20 mL of water) was added to 2 mmol  of the  ligand solution (0.420 g of L
1H2, 
0.442 g of L
2H2 or 0.442 g of L
3H2 in 15 mL of ethanol) with stirring. An initial sharp decrease in 
the pH of the solution from 5.5 to 3-3.5 was observed. After raising the pH to 5-5.5 using a 1% 
aqueous NaOH solution, the reaction mixture was kept in a hot water bath (60C) for 2 hours to 
complete the precipitation. Then the precipitated complexes were filtered, washed with water and 
dried at room temperature in a vacuum oven. Results of the spectroscopic and composition analyses 
are shown as follows. Proposed structures of complexes are shown in Figures 1 and 2.  
[Ni(L
1H)2]: yield  60 %; m.p. >400C; colour red;  IR (KBr, cm
-1) 3437 (N-H), 3105 (C-
Harom.), 1578 (C=Noxime), 1633 (C=Nhydr.), 1882 (H...OH), 947 (N-O); UV-Vis (DMSO, λmax/nm) 
221, 350, 490. For C16H18O6N8Ni (477.058 g.mol
-1), calculated:  40.28 % C, 3.80 % H, 23.49 % N; 
found: 40.48 % C, 3.66 % H, 23.36 % N. 
 [Cu(L
1H)2]: yield  60 %; m.p. >400C; colour brown;  IR (KBr, cm
-1) 3433 (N- H), 3120 
(C-Harom.), 1567 (C=Noxime), 1622 (C=Nhydr.), 1735 (H...OH), 956 (N-O); UV-Vis (DMSO, λmax/nm) 
266, 322, 390.  For C16H18O6N8Cu (481.910   g.mol
-1), calculated:  39.88 % C, 3.76 % H, 23.25 % 
N; found: 39.03 % C, 3.87 % H, 23.68 % N. 
 [Co(L
1H)2(H2O)2]: yield  60 %; m.p. >400C; colour brown;  IR (KBr, cm
-1) 3398 (N-H), 
3121 (OH/H2O),  3109 (C-Harom.), 1573 (C=Noxime), 1623 (C=Nhydr.), 1762 (H...OH), 949 (N-O); 
UV-Vis (DMSO, λmax/nm) 255, 310, 390. For C16H22O8N8Co (513.328 g.mol
-1), calculated:  37.44 
% C, 4.32 % H, 21.83 % N; found: 37.20 % C, 3.94  % H, 22.32 % N.  
[Ni(L
2H)2]: yield  60 %; m.p. >400C; colour red;  IR (KBr, cm
-1) 3444 (N-H), 3109 (C-
Harom.), 1578 (C=Noxime), 1652 (C=Nhydr.), 1782 (H...OH), 942 (N-O); UV-Vis (DMSO, λmax/nm) 
273, 388, 482. For C18H20O4N10Ni (499.110 g.mol
-1), calculated:  43.32 % C, 4.04 % H, 28.06 % N; 
found: 43.08 % C, 4.34 % H, 27.44 % N. 
[Cu(L
2H)2]: yield  60 %; m.p. >400C; colour brown;  IR (KBr, cm
-1) 3393 (N-H), 3066 (C-
Harom.), 1574 (C=Noxime), 1648 (C=Nhydr.), 1782 (H...OH), 941 (N-O); UV-Vis (DMSO, λmax/nm) 
267, 300, 390. For C18H20O4N10Cu (503.962 g.mol
-1), calculated:  42.90 % C, 4.00 % H, 27.79 % 
N; found: 43.58 % C, 4.51 % H, 27.68 % N. 
[Co(L
2H)2(H2O)2]: yield  (60 %); m.p. >400C; colour brown;  IR (KBr, cm
-1) 3380 (N-H), 
3194 (OH/H2O), 3072 (C-Harom.), 1562 (C=Noxime), 1636 (C=Nhydr.), 1749 (H...OH), 941 (N-O); 
N H
OH
N
OH
NH
N H2 + CH3COOH
 EtOH- H 2O
N
CH3
O N H
O H
N
OH
NH
N
C H3
N30 
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UV-Vis (DMSO, λmax/nm) 264, 294, 404. For C18H24O6N10Co (535.380 g.mol
-1), calculated:  40.38 
% C, 4.52 % H, 26.16 % N; found: 40.54 % C, 4.51 % H, 26.86 % N. 
[Ni(L
3H)2]: yield  60 %; m.p. >400C; colour red;  IR (KBr, cm
-1) 3437 (N-H), 3047 (C-
Harom.), 1588 (C=Noxime), 1629 (C=Nhydr.), 1855 (H...OH), 950 (N-O); UV-Vis (DMSO, λmax/nm) 
270, 335, 498. For C18H20O4N10Ni (499.110 g.mol
-1), calculated:  43.32 % C, 4.04 % H, 28.06 % N; 
found: 43.62 % C, 4.34 % H, 27.38 % N. 
[Cu(L
3H)2]: yield  60 %; m.p. >400C; colour brown;  IR (KBr, cm
-1) 3422 (-NH), 3086 (C-
Harom.), 1562 (C=Noxime), 1634 (C=Nhydr.), 1782 (H...OH), 949 (N-O); UV-Vis (DMSO, λmax/nm) 
258, 270, 394. For C18H20O4N10Cu (503.962 g.mol
-1), calculated:  42.90 % C, 4.00 % H, 27.79 % 
N; found: 42.64 % C, 3.58 % H, 27.35 % N. 
[Co(L
3H)2(H2O)2]: yield  60 %; m.p. >400C; colour brown;  IR (KBr, cm
-1) 3397 (N-H), 
3225 (OH/H2O), 3050 (C-Harom.), 1589 (C=Noxime), 1616 (C=Nhydr.), 1776 (H...OH), 946 (N-O); 
UV-Vis (DMSO, λmax/nm) 258, 279, 395. For C18H24O6N10Co (535.380 g.mol
-1), calculated:  40.38 
% C, 4.52 % H, 26.16 % N; found: 40.85 % C, 5.05 % H, 25.94 % N. 
 
 
 
 
 
 
 
 
 
Figure 1. Suggested structure of Co(II)·2H2O, Ni(II) and Cu(II) complexes of 5-methyl-2-
furfuraldehyde hydrazone glyoxime  
 
 
 
 
 
 
 
 
 
Figure 2. Suggested structure of the Co(II)·2H2O, Ni(II) and Cu(II) complexes of L
2H2 and L
3H2 
(3-acetylpyridine for L
2H2 and 4-acetlypyridine for L
3H2) 
 
Biological Studies 
 
Eight bacterial strains and one yeast strain were obtained from the American Type Culture 
Collection (ATCC, Rockville, MD, USA). Other strains were obtained from Faculty of Medicine, 
Adnan  Menderes  University.  The  Gram-negative    (G-)  were:  Escherichia  coli    ATCC  25922, 
Salmonella typhimurium ATCC 14028, Proteus sp., Serratia  marcescens and Enterobacter sp., and 
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the  Gram-positive  (G+)  were:  Micrococcus  luteus  ATCC  9341,  Staphylococcus  aureus  ATCC 
25923,  Staphylococcus  epidermidis  ATCC    12228,  Bacilllus    cereus  ATCC  11778,  Bacillus 
thuringiensis, Enterococcus faecalis ATCC 29212, Streptococcus pneumoniae ATCC 49617 and 
Listeria  sp.    The  following  five  yeast  strains,  i.e.  Candida  utilis,  C.  albicans,  C.  glabrata,  C. 
Tropicalis and Saccharomyces cerevisiae ATCC 9763, were also tested using disc diffusion method 
[21, 22] and the minumum inhitory concentration (MIC) was determined by broth dilution method 
[23]. 
 
Disc diffusion method 
  
    Screening for antibacterial and antifungal activities were carried out using sterile antibiotic 
discs (6 mm), following the standard procedure of Antimicrobial Disc Susceptibility Tests outlined 
by  the  National  Committee  for  Clinical  Laboratory  Standards-NCCLS  [21,  22].  Fresh  stock 
solutions  (30  µg.mL
-1)  of  the  ligands  were  prepared  in  DMSO  according  to  the  needed 
concentrations for the experiments.  
    The inoculum suspensions of the tested bacteria and yeasts were prepared from the broth 
cultures (18-24 hr) and the turbidity equivalent adjusted to 0.5 McFarland standard tube to give a 
concentration of 1x10
8 bacterial cells and 1x10
6 yeast cells/mL. To test the antimicrobial activity of 
each aromatic hydrazone derivative bearing vic-dioxime group or its complex, a Mueller Hinton 
agar plate was inoculated with 0.1 mL broth culture of bacteria or yeast. Then a hole of 6 mm in  
diameter and depth was made on top with a sterile stick and filled with 10 μL of the hydrazone 
derivative or its complex containing vic-dioxime group. 
  Plates  inoculated with E. coli   ATCC 25922, S. typhimurium  ATCC 14028,   S. aureus 
ATCC  25923,  S.  epidermidis  ATCC    12228,  E.  faecalis  ATCC  29212,  S.  pneumoniae  ATCC 
49617, Listeria sp., Proteus sp., S. Marcescens and Enterobacter sp. were incubated at 37
C for 24 
hr and those inoculated with M. luteus ATCC 9341, B.  cereus ATCC 11778, B.  thuringiensis, S. 
cerevisiae  ATCC 9763, C. albicans  ATCC 90028, C. glabata, C. utilis and  C. tropicalis were 
incubated at 30
C  for 24 hr. The diameter of the  inhibition zone was then  measured. Discs of 
chloramphenicol (C30, Oxoid), gentamycin (GN10 Oxoid), nystatin (NS100 Oxoid) were used as 
positive controls. The inhibition zones were compared with those of the reference discs.   
 
Dilution method 
  
  Screening for antibacterial and antifungal activities were carried out by preparing a micro-
dilution broth, following the procedure outlined in Manual of Clinical Microbiology [23]. All the 
bacteria were inoculated in the nutrient broth and incubated at 30-37C for 24 hr while the yeasts 
were  inoculated  in  malt  extract  broth  and  incubated  at  30C  for  48  hr.  The  compounds  were 
dissolved in DMSO (2 mg mL
-1) and then diluted in Mueller Hinton broth. Twofold serial dilution 
of the compounds were employed to determine the MIC ranging from 256 to 1.0 µg mL
-1. Cultures 
were grown at 30-37C (18-20 hr) and the final inoculum was approximately 10
6 cfu mL
-1. Test 
cultures  were  incubated  at  37C  (24  hr).  The  lowest  concentration  of  antimicrobial  agent  that 
resulted  in  complete  inhibition  of  the  microorganisms  was  represented  as  MIC  (µg  mL
-1).  As 
positive controls, streptomycin (I. E. Ulagay) for bacteria and nystatin (NS100, Oxoid) for yeast 
were used in the dilution method. In each case, the test was performed in triplicate and the results 
were expressed as means. 
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RESULTS AND DISCUSSION 
 
  Some physical properties, elemental analysis results and magnetic susceptibility data of the 
ligands and complexes are summarised in Table 1. FT-IR data of the ligands and their complexes 
are given in Table 2. 
1H-NMR and 
13C-NMR data of the ligands are given in Table 3. Attempts to 
isolate crystals suitable for X-ray diffraction were unsuccessful for the ligands and complexes. 
1H-
NMR  and 
13C-NMR  spectra of  these  complexes  could not  be taken  because  of  their  very  low 
solubility in organic solvents. FT-IR, UV, elemental analysis and magnetic susceptibility techniques 
were employed in order to determine the structural characteristics of the complexes. Antimicrobial 
activities of the ligands and their metal complexes are given Tables 4 and 5. 
 
IR Spectra 
 
  The IR spectra of the new hydrazone-oxime compounds (L
1H2, L
2H2 and L
3H2) were in 
accord with the previously reported oxime derivatives [16, 20, 24-27]. In the IR spectra of Co(II) 
complexes, the weak deformation  vibration  band assigned to the intramolecular  hydrogen  bond     
O-H....O bending vibration was observed around 1749-1776 cm
−1 [16, 20, 27]. The C=Noxime stretch 
decreased from 1608-1605 cm
−1 in the free ligands to 1589-1562 cm
−1 in the Co(II) complexes
 [22, 
25, 28]. The coordinated H2O molecules of (L
1H)2Co(H2O)2 and (L
2H)2Co(H2O)2 were identified 
by a broad OH absorption around 3225-3194 cm
−1 with constant intensities after heating above 
110C for 24 hr. The IR spectra of Ni(II) and Cu(II) complexes exhibited a C=Noxime stretching 
vibration around 1588-1562 cm
−1. These vibrations were at a lower frequency than for the free 
ligands, which were attributed to N,N- chelation [16, 20, 26-31].    
    A weak band around 1882-1735 cm
−1 can be assigned to the intramolecular hydrogen bond 
O-H....O bending vibration [16-20, 31]. The intensity of the characteristic stretching and bending 
vibrations of the free ligands  shifted and lowered on complex formation and new vibrational bands 
characteristic of the Ni(II) and Cu(II) complexes were observed. 
    The dioxime ligand, a neutral compound, forms, when complexed, a monoanion by the loss 
of an oxime proton with concomitant formation of an intra-molecular hydrogen bond. The cobalt 
ion coordinates with the ligand through its nitrogen donors in the equatorial positions [31]. The 
band O-H...O is absent in the ligand but appears in the spectrum of the complexes, showing that the 
Ni(II) and Cu(II) complexes have a square-planar structure 
 (Figure 1). 
 
NMR Spectra  
 
The  signals  in  the 
1H-NMR  spectra  of  the  ligands  were  in  accord  with  the  previously 
reported oxime derivatives [24, 31]. Two peaks were observed for the O-H protons of the oxime 
groups. These two deuterium-exchangeable singlets correspond to two inequivalent O-H protons 
that also indicate the anti-configuration of the O-H groups relative to each other [29-32].  
    In the 
13C-NMR spectra of the ligands, different signals which were observed at 154.64 ppm 
for L
1H2,  149.83 ppm for L
2H2 and 150.50 ppm for L
3H2 (HNC=N-OH), together with 150.34 ppm 
for  L
1H2,  147.58  ppm  for  L
2H2  and  146.17  ppm  for  L
3H2  (H-C=N-OH)  showed  that  the  vic-
dioximes are asymetrically substituted [25, 33]. The two different frequencies in each case also 
indicate that the vic-dioxime has anti structure [25].  
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Maejo Int. J. Sci. Technol.  2013, 7(01), 26-41 
 
Table 1.  Physical properties and elemental analyses of the ligands and complexes 
________________________________________________________________________________________ 
Compound Formula          m.p.
         (%)
   µeff
 a
                                             Calculated (Found) %  
                                   (ºC)      Yield    Colour             (BM)
                C                        H                    N                                                               
_____________________________________________________________________________________ 
 
L
1H2                                                   118         65      Yellow            -               45.71(45.65)        4.80 (4.46)   26.66 (26.24) 
 
[Ni(L
1H)2]                      > 400       60       Red                Dia.            40.28 (40.48)       3.80 (3.66)   23.49 (23.36) 
 
[Cu(L
1H)2]                     > 400        47       Brown          1.75            39.88 (39.03)        3.76 (3.87)   23.25 (23.68) 
 
[Co(L
1H)2(H2O)2]          > 400       60        Brown           4.40           37.44 (37.20)        4.32 (3.94)   21.83(22.32) 
 
L
2H2                                               146.5        64        Yellow             -              48.86 (48.65)        5.01 (4.46)  31.66 (31.24) 
 
[Ni(L
2H)2]                      > 400       60       Red                 Dia.           43.32 (43.08)       4.04 (4.34)   28.06 (27.44) 
 
[Cu(L
2H)2]                      > 400       55       Brown            1.75           42.90 (43.58)       4.00 (4.51)   27.79 (27.68) 
 
[Co(L
2H)2(H2O)2]           > 400       57       Brown             4.10          40.38 (40.54)       4.52 (4.51)   26.16 (26.86) 
 
L
3H2                                                  136        68        Yellow               -            48.86 (48.69)       5.01 (5.34)   31.66 (31.37) 
 
[Ni(L
3H)2]                     > 400        60        Red                Dia.           43.32 (43.62)       4.04 (4.34)   28.06 (27.38) 
 
[Cu(L
3H)2]                     > 400        57        Brown          1.73            42.90 (42.64)       4.00 (3.58)    27.79 (27.35) 
 
[Co(L
3H)2(H2O)2]         > 400         50        Brown           4.21           40.38 (40.85)        4.52 (5.05)   26.16 (25.94) 
______________________________________________________________________________________               
  a magnetic moment (Dia. = diamagnetic)
  
 
 
Table 2. Characteristic IR bands (cm
-1) of the vic-dioxime ligands and their metal complexes  
___________________________________________________________________________  
Compound             (N-H)      (O-H)       (C=N)oxime      (C=N)hydr.    (C-H)arom.   (C-H)aliph.             (N-O)       (OH...O) 
                                             (OH/H2O) 
___________________________________________________________________________ 
 
L
1H2                                  3256 (b)    3124 (b)    1608 (s)     1644 (s)    3068 (w)    2935-2820 (w)    953 (m)          - 
 
[Ni(L
1H)2]             3437 (b)       -             1578 (s)     1633 (s)    3105 (w)    2920- 2898 (w)    947 (m)     1882 (w) 
 
[Cu(L
1H)2]            3433 (b)       -             1567 (s)     1622 (s)    3120 (w)     2912-2850 (w)    956 (m)      1735 (w) 
 
[Co(L
1H)2(H2O)2] 3398 (b)   3121 (b)     1573 (s)     1623 (s)    3109 (w)     2916-2835 (w)    949 (m)     1762 (w)  
     
L
2H2                                  3364 (b)   3180 (b)     1605 (s)     1656 (s)    3066 (w)    2942-2808 (w)     962 (m)                              - -          
       
[Ni(L
2H)2]             3444 (b)       -             1578 (s)     1652 (s)    3109 (w)    2912-2850 (w)     942 (m)     1782 (w)   
       
[Cu(L
2H)2]            3393 (b)       -             1574 (s)      1648 (s)    3066 (w)    2908-2850 (w)     942 (m)    1782 (w)  
       
[Co(L
2H)2(H2O)2] 3380 (b)   3194 (b)    1562 (s)       1636 (s)    3072 (w)    2919-2851 (w)    941 (m)     1749 (w) 
        
L
3H2                                 3340 (b)    3161 (b)    1605 (s)      1640 (s)    3073 (w)     2957-2844(w)     960 (m)          -             
        
[Ni(L
3H)2]            3437 (b)       -             1588 (s)       1629 (s)    3047 (w)    2920-2843 (w)     950 (m)    1855 (w) 
 
[Cu(L
3H)2]           3422 (b)       -             1562 (s)       1634 (s)    3086 (w)    2924-2850 (w)     949 (m)    1782 (w) 
 
[Co(L
3H)2(H2O)2] 3397 (b)   3225 (b)    1589 (s)       1616 (s)    3050 (w)    2912-2858 (w)     946 (m)    1776 (w) 
________________________________________________________________________________________         
Note: s = strong, m = medium, w = weak, b = broad 
 
 34 
Maejo Int. J. Sci. Technol.  2013, 7(01), 26-41 
 
Table 3. Important 
1H-NMR and 
13C-NMR signals (ppm) of ligands in DMSO-d6 
_______________________________________________________________________________________________________________ 
____________________________________________________________________________ 
  
1H-NMR  
___________________________________________________________________________                                          
-OH
a                         -NH
a                             Ar-H                    CH=NOH         CH=NNH         -CH3 
_______________________________________________________________________________________ 
 
L
1H2          11.50-10.65, s, 2H   10.18, s, 1H       7.00, 6.20, d, 2H        6.70, s, 1H      7.80, s, 1H       2.20, s, 3H 
                   
L
2H2          11.50-10.70, s, 2H    8.82, s, 1H         8.50, 7.94, d, 2H       7.82, s, 1H            -                 2.13, s, 3H 
                                                                       8.70 s, 1H, 7.53, t, 1H 
 
L
3H2          11.60-10.87, s, 2H   8.92, s, 1H           8.54, 7.99, d, 4H       7.61, s, 1H           -                  2.19, s, 3H 
__________________________________________________________________________________________ 
 
13C-NMR  
_______________________________________________________________________________________                          
      HNC=NOH             HC=NOH             Me(H)C=NNH                        Ar-C                        -CH3 
_______________________________________________________________________________________ 
 
L
1H2                       154.64                      150.34                      158.80                       148.48-126.33                  14.14 
 
L
2H2                       149.83                      147.58                      154.06                       146.47-124.08                  12.69 
 
L
3H2                       150.50                      146.17                      151.45                       143.34-121.96                  12.20 
________________________________________________________________________________________   
a Disappears on D2O exchange. 
 
 
Table 4.  Antimicrobial activities of ligands and their metal complexes (Inhibition zone in mm) 
 
 
Test 
Microorganism 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
11 
 
12 
 
GN10 
 
C30 
 
NS100 
 
Escherichia coli  
 ATCC 25922            
-  -  -  -  -  -  -  -  -  -  -  -  21  24  NT 
Salmonella 
 typhimurium   
 ATCC 14028        
-  -  -  -  -  -  -  -  -  -  -  -  16  17  NT 
Proteus sp.*  -  -  -  -  -  -  -  -  -  -  -  -  24  17  NT 
Serratia 
 marcescens* 
-  -  -  -  -  -  -  -  -  -  -  -  19  23  NT 
Micrococcus 
 luteus,ATCC 
9341     
-  -  -  -  -  -  -  -  -  -  -  -  15  25  NT 
Enterobacter 
sp.* 
-  -  -  -  -  -  -  -  -  -  -  -  20  19  NT 
Staphylococcus 
aureus  ATCC 
25923   
-  -  -  -  -  -  -  -  -  -  -  12  20  23  NT 
Staphylococcus 
 epidermidis  
ATCC  12228              
-  -  -  -  -  -  -  -  -  -  -  11  17  22  NT 
Bacilllus  
cereus 
ATCC 11778 
10  -  -  -  -  11  12  -  -  11  11  18  24  23  NT 
Bacillus  
 thuringiensis*             
-  -  -  13  -  -  -  -  13  -  -  12  21  26  NT 35 
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Table 4.  (Continued) 
 
 
Test 
Microorganism 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
11 
 
12 
 
GN10 
 
C30 
 
NS100 
 
Enterococcus       
 faecalis 29212 
-  -  -  -  -  -  -  -  -  -  -  -  11  16  NT 
Streptococcus 
 pneumoniae  
ATCC 49617             
9  -  -  -  -  -  -  -  -  -  -  13  20  24  NT 
Listeria sp*       
           
-  -  -  -  -  -  -  -  -  -  -  -  11  16  NT 
Candida utilis*  
          
-  -  -  10  -  -  -  -  -  -  -  17  NT  NT  21 
Candida 
albicans*      
-  -  -  -  -  -  -  -  -  -  -  -  NT  NT  21 
Candida 
glabata*       
-  -  -  -  -  -  -  -  -  -  -  -  NT  NT  15 
Candida 
 tropicalis*               
-  -  -  -  13  -  -  -  14  12  -  -  NT  NT  15 
Saccharomyces 
 cerevisiae  
ATCC 9763                
11  -  -  -  -  11  10  -  10  -  -  -  NT  NT  15 
 
Note: 1= L
1H2, 2= [Ni(L
1H)2], 3= [Cu(L
1H)2], 4= [Co(L
1H)2(H2O)2], 5= L
2H2, 6= [Ni(L
2H)2], 7= [Cu(L
2H)2],  
8= [Co(L
2H)2(H2O)2], 9= L
3H2, 10= [Ni(L
3H)2], 11= [Cu(L
3H)2], 12= [Co(L
3H)2(H2O)2] 
C30= chloramphenicol, GN10= gentamycin, NS100= nystatin 
(-)= No zone, NT= Not tested 
* from Faculty of Medicine, Adnan Menderes University  
 
 
Table 5. Antimicrobial activities of ligands and their metal complexes (MIC, µg.mL
-1)  
 
Test Microorganism 
1  4  5  6  7  9  10  11  12  Str 
NS100 
 
Bacilllus  cereus 
 ATCC 11778  8 
_ 
 
_ 
 
8  16 
_ 
 
128  8 
_ 
 
64 
_ 
 
Bacillus  thuringiensis*  _ 
 
16 
_ 
 
_ 
 
_ 
 
64 
_ 
 
_ 
 
32  64 
_ 
 
Streptococcus 
pneumoniae ATCC 
49617 
 
16 
_  _  _  _  _  _  _  128  128 
_ 
 
Candida utilis* 
 
_ 
 
4 
_ 
 
_ 
 
_ 
 
_ 
 
_ 
 
_ 
 
4 
_ 
 
64 
Candida tropicalis* 
 
_ 
 
_ 
 
8 
_ 
 
_ 
 
16  8 
_ 
 
_ 
 
_ 
 
64 
Saccharomyces 
cerevisiae ATCC 9763  16 
_ 
 
_ 
 
16 
_ 
 
32 
_ 
 
_ 
 
_ 
 
_ 
 
128 
 
Note: 1= L
1H2, 2= [Ni(L
1H)2], 3= [Cu(L
1H)2], 4= [Co(L
1H)2(H2O)2], 5= L
2H2, 6= [Ni(L
2H)2], 7= [Cu(L
2H)2],  
8= [Co(L
2H)2(H2O)2], 9= L
3H2, 10= [Ni(L
3H)2], 11= [Cu(L
3H)2], 12= [Co(L
3H)2(H2O)2] 
Compounds 2,3,8 did not show antibacterial activity. 
Str= streptomycin, NS100= nystatin 
(-)=  no effect 
* from Faculty of Medicine, Adnan Menderes University 36 
Maejo Int. J. Sci. Technol.  2013, 7(01), 26-41 
 
Magnetic Susceptibility 
     
  The  magnetic  susceptibility  measurements  of  the  Ni(II)  complexes  indicate  that  these 
complexes are diamagnetic while the Co(II) and Cu(II) complexes are paramagnetic. The copper 
complexes showed 1.75 BM for L
1H2, 1.75 BM for L
2H2 and 1.73 BM for L
3H2. These results 
indicate square-planar structures for the Cu(II) complexes [20, 25, 33-36]. The cobalt complexes 
showed 4.40 BM for L
1H2, 4.10 BM for L
2H2 and 4.21 BM for L
3H2. The microanalysis shows that 
the complexes of Co(II) can be octahedral [20, 25, 33]. Therefore, square-planar geometry for the 
Ni(II)  and  Cu(II)  complexes  and  octahedral  geometry  for  the  Co(II)  complexes  are  proposed 
(Figures 1 and 2). 
 
UV Spectra 
 
The bands in the electronic spectra of the Ni(II), Cu(II) and Co(II) complexes were assigned 
to both a charge transfer transition from the metal to the anti-bonding orbital of the ligand and to a 
spin-allowed transition of the ligand. The general character of the spectra was very similar to that of 
the corresponding complexes of symmetrically disubstituted dioximate ligands.  The d
8 metal ion, 
Ni(II), exhibited a preference for square planar geometry with the dioxime complexes. The decrease 
in the intensities of the transitions indicates coordination with the nitrogen atoms [37, 38]. 
 
Antimicrobial Assays 
 
The three novel aromatic hydrazone derivatives containing vic-dioxime groups and their 
Ni(II), Cu(II) and Co(II) complexes exhibited moderate antimicrobial activity (Tables 4 and 5). 
Among the test compounds attempted, compounds 1, 4, 6, 7, 9, 10 and 12 showed slightly higher 
activity against some bacteria and yeasts (Table 4). The MIC values (Table 5) also indicate that 
some of the compounds tested exhibited moderate antimicrobial activity. Compounds 1, 4, 6, 7, 9, 
10 and 12 showed stronger activity against some bacteria (B. thuringiensis, B. cereus ATCC 11778 
and Streptococcus pneumoniae ATCC 49617) compared with streptomycin. These compounds also 
had strong activity against the yeasts (Saccharomyces cerevisiae ATCC 9763, Candida utilis and 
Candida tropicalis) compared with nystatin. 
  All  the  ligands  and  their  metal  complexes  studied  had  no  effect  on  the  Gram-negative 
bacteria. In general, the  ligands and their  metal complexes  have antimicrobial activities against 
Gram-positive bacteria, especially B. cereus ATCC 11778, B.  thuringiensis, S. pneumoniae ATCC 
49617 and yeasts, S. cerevisiae ATCC 9763 and C. tropicalis C. utilis.   
  Members  of  the  genus  Bacillus  are  aerobic  spore-forming  rods  which  are  ubiquitous  in 
nature [39]. Despite their widespread distribution, even as normal skin flora, Bacillus spp. rarely 
cause infections. An exception is Bacillus cereus, which is a well-known cause of food poisoning 
and dreaded post-traumatic endophthalmitis [39]. B. cereus can also cause opportunistic infections, 
mainly in the immuno-compromised host [39, 40].  Although B. anthracis and B. cereus behave as 
human pathogens and B. thuringiensis is a common insect pathogen, genetic evidence indicates that 
these microorganisms should be regarded as unique species [41].  B. thuringiensis has been used 
worldwide as a biopesticide in forestry and agriculture  [41, 42], being non-pathogenic to humans 
and able to produce potent species-specific insecticidal activities. More recently, however, repeated 
observations  are  documenting  the  association  of  this  microorganism  with  various  infectious 
diseases  in  humans  such  as  food-poisoning  associated  diarrhoea  [43],  corneal  ulcer  [44], 
periodontitis [39], and burn [45] and wound [46] infections.  37 
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    The term candidiasis is often used to describe an infection caused by a yeast-like fungus 
Candida albicans. Species of Candida other than C. albicans, however, have the potential to cause 
infection, particularly in patients who are immunologically or physiologically compromised [44, 
45]. Candida tropicalis has emerged as a potentially dangerous opportunistic fungus. This may be 
due both to an increased awareness and specific identification of C. tropicalis as an etiologic agent 
of infection and to an increase in the number of compromised patients susceptible to opportunistic 
fungi. C. tropicalis has been shown to be the most frequent opportunistic fungus isolated from 
specimens from patients in a critical care unit [45, 46]. C. tropicalis has also been reported to be a 
frequent opportunistic pathogen in a cancer hospital [47] and has been identified as the etiologic 
agent  in  a  variety  of  infections  including  pyelonephritis  [48],  lower  urinary  tract  infection,  
thrombophlebitis, arthritis, bursitis,  meningitis, multiple organ infection, pericarditis and candida 
vulvovaginitis [47, 49].  
Suggestions are made that the negative inductive effect plays a significant role. Dimerisation 
of oxime involves the formation of a pair of H bonds [19, 50]. This feature causes a decrease in 
electronic density of oximes compared  with phenylhydrazones, thereby  facilitating entry of the 
oxime into the cell. This is likely to increase the antibacterial potency [19, 50]. 
  A comparative study of the ligands and their complexes as antibacterial agents indicates that 
the metal complexes are more active than the free ligands [19, 50]. Such increased activity of the 
metal chelates can be explained by the reduced polarity of the ligand due to the overlap of the 
ligand orbital and partial sharing of the positive charge of the metal ion with electron releasing 
groups. It is obvious that reducing the total electron density on free ligands makes the diffusion 
proceed faster through the bacterial cells [51]. 
It is generally observed that metal chelates have higher antibacterial activity than the free 
ligand due to an increase in cell permeability. The lipid membrane which surrounds the cell favours 
only the passage of lipid soluble materials and it is known that liposolubility is an important factor 
controlling  antimicrobial  activity  [52-54].  Such  screening  of  various  organic  compounds  and 
identifying the active agents are essential because the successful prediction of a lead molecule and 
the drug-like properties at the onset of drug design will pay off later in drug development. 
 
CONCLUSIONS 
 
  Three novel vic-dioxime derivatives containing hydrazone side groups and their transition 
metal complexes with Ni(II), Cu(II) and Co(II) were synthesised. The antimicrobial activities of 
compounds (L
1H2, L
2H2, L
3H2 and their Ni(II), Cu(II) and Co(II) complexes) were evaluated using 
disc diffusion method against 13 bacteria and 5 yeasts. Minimal inhibitory concentration (MIC) 
dilution  against  3  bacteria  and  3  yeasts  were  also  determined.  Among  the  test  compounds 
attempted,  L
1H2,  [Co(L
1H)2(H2O)2],  [Ni(L
2H)2],  [Cu(L
2H)2],  L
3H2,  Ni(L
3H)2  and  [Co(L
3H)2(H2O)2] 
showed activities against certain Gram-positive bacteria and certain  yeasts.  Some of them were 
comparatively higher or equipotent to the antibiotic and antifungal agents in the comparison tests. 
These compounds appeared to have moderate antibacterial and antifungal activity. 
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